🔓 Unlock the full profile of Raveendranath Govindaraj (Lab Iconics Technologies), including verified contact details, financial insights, and professional associations.
See Raveendranath Govindaraj Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: rav*****@lab******.com
Mobile: 75504*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Raveendranath Govindaraj established Lab Iconics Technologies LLP in October 2018, serving as Founder & Managing Partner, contributing significantly to advancements in the technology sector.
- Prior to founding Lab Iconics, Raveendranath held the role of Team Lead - GMP Operations & Facilities at GlaxoSmithKline Consumer Private Limited from October 2015 until September 2018, where responsibilities included overseeing compliance with Good Manufacturing Practices.
- From January 2015 to September 2015, Raveendranath worked as Head - Site Services at Novartis, focusing on optimizing operational efficiency and facility management.
- In Mylan Laboratories Limited, from March 2009 to January 2015, Raveendranath served as DGM - Analytical Instrumentation, where contributions included enhancing analytical capabilities and instrumentation processes.
- Raveendranath managed instrumentation at Jubilant Biosys as Manager from August 2007 to March 2009, playing a key role in ensuring the functionality and reliability of scientific instruments.
- Served as Assistant Manager - Instrumentation at Orchid Healthcare - Generics from July 2003 to August 2007, contributing to the development of instrumentation strategies for production processes.
- Beginning the career as a Service Engineer - HPLC at Waters India Pvt Ltd from April 2001 to July 2003, focused on servicing and maintaining high-performance liquid chromatography systems, which laid the groundwork for future roles in instrumentation.
- Throughout the various roles, Raveendranath consistently demonstrated leadership, innovation, and a commitment to quality in the technology and pharmaceutical sectors.